Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
91 studies found for:    atherosclerosis OR arteriosclerosis OR hardening of the arteries | Open Studies | NIH, U.S. Fed
Show Display Options
Rank Status Study
21 Not yet recruiting Predictors of Coronary Artery Calcium Progression in Adults With a Prior Zero Coronary Artery Calcium Score
Conditions: Coronary Artery Disease;   Endothelial Dysfunction;   Atherosclerosis
Intervention:
22 Recruiting Safety of PZ-128 in Subjects Undergoing Non-Emergent Percutaneous Coronary Intervention
Conditions: Arterial Occlusive Diseases;   Coronary Artery Disease;   Coronary Disease;   Arteriosclerosis;   Heart Diseases;   Myocardial Ischemia;   Vascular Diseases;   Acute Coronary Syndrome
Interventions: Drug: PZ-128;   Drug: Placebo
23 Recruiting Technical Development of Cardiovascular Magnetic Resonance Imaging
Condition: Peripheral Artery Disease
Intervention: Procedure: MRI
24 Unknown  Mechanisms That Produce the Leg Dysfunction of Claudication (Leg Pain and Limping During Walking) and Treatment Strategies for the Care of Patients With Claudication
Condition: Peripheral Arterial Disease
Interventions: Procedure: Revascularization Surgery;   Other: Supervised exercise therapy
25 Recruiting Intima Versus Adventitia Drug Delivery to Elucidate Mechanisms of Restenosis: Magnetic Resonance Imaging
Conditions: Peripheral Artery Disease;   Vascular Disease;   Critical Limb Ischemia
Interventions: Drug: Dexamethasone infusion;   Device: Drug coated balloon
26 Recruiting ClinSeq: A Large-Scale Medical Sequencing Clinical Research Pilot Study
Conditions: Cardiovascular Disease;   Coronary Artery Calcification
Intervention:
27 Recruiting Platelet Activity in Vascular Surgery and Cardiovascular Events
Conditions: Cardiovascular Disease;   Peripheral Artery Disease;   Critical Limb Ischemia
Intervention:
28 Unknown  Caveolin-1 and Vascular Dysfunction
Conditions: Hypertension;   Insulin Resistance
Interventions: Drug: Para-aminohippuric Acid;   Drug: Angiotensin II;   Drug: Norepinephrine
29 Recruiting Sex Hormones and Atherosclerosis Prevention in Perimenopausal Women
Conditions: Menopause;   Aging
Interventions: Drug: KUVAN;   Drug: Placebo;   Drug: Cetrotide;   Drug: Climara;   Drug: Placebo transdermal patch
30 Recruiting Role of PPAR-y Agonists in Immunomodulation and Vascular Prevention in SLE (PPAR-SLE)
Condition: Systemic Lupus Erthematosus
Interventions: Radiation: PET/CT;   Drug: Pioglitazone;   Procedure: Vascular function studies
31 Not yet recruiting GEOHealth Hub: Household Air Pollution and Cardio-pulmonary and Immune Function Outcomes
Conditions: Household Air Polution;   Cardiovascular Diseases;   Lung Diseases;   Immune Dysfunction
Intervention: Device: Improved cook stove
32 Recruiting Genes Involved in Lipid Disorders
Condition: Dyslipidemia
Intervention:
33 Recruiting Asymptomatic Carotid Stenosis: Cognitive Function and Plaque Correlates
Condition: Cognitive Manifestations
Intervention:
34 Recruiting Technical Development of Cardiovascular Magnetic Resonance Imaging
Condition: Cardiovascular Disease
Intervention:
35 Recruiting A Study of the Gut Barrier and Blood Vessel Inflammation in Individuals With and Without HIV
Condition: HIV
Interventions: Drug: Teduglutide;   Drug: Placebo
36 Recruiting Cardiovascular Disease Study
Condition: Spinal Cord Injury
Interventions: Procedure: 2 hour Oral Glucose Tolerance Test;   Procedure: Fat Meal Test
37 Unknown  SmartRisk Stroke Prediction by MRI of Carotid Disease
Condition: Atherosclerotic Disease, Carotid
Intervention:
38 Recruiting Effect of Short-Term Beta-Cell Rest in Adolescents and Young Adults With Type 2 Diabetes Mellitus
Conditions: Obesity;   Overweight;   Diabetes Mellitus, Type 2
Intervention:
39 Recruiting Physical Activity Behavior Change for Older Adults After Dysvascular Amputation
Conditions: Amputation;   Diabetes Mellitus, Type 2;   Peripheral Artery Disease
Intervention: Behavioral: Physical Activity Behavior Change (PABC)
40 Recruiting Excellence In Peripheral Artery Disease Thrombin Receptor Antagonist Intervention In Claudication Evaluation (XLPAD-TRACE Trial)
Condition: Peripheral Arterial Disease
Interventions: Drug: Placebo + background APT + SMT;   Drug: Vorapaxar 2.08 mg/d + background APT + SMT.

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years